KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
1.175
-0.175 (-12.96%)
At close: Jul 10, 2026, 4:00 PM EDT
1.180
+0.005 (0.43%)
After-hours: Jul 10, 2026, 5:07 PM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $21.84 million as of July 10, 2026. Its market cap has decreased by -27.91% in one year.
Market Cap
21.84M
Enterprise Value
14.10M
1-Year Change
-27.91%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $21.84M, a decrease of -94.93%. That is a compound annual growth rate of -28.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 21.84M | 374.85% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 27.93M |
| IGC Pharma | 27.71M |
| Evaxion | 27.48M |
| GridAI Technologies | 27.25M |
| Marker Therapeutics | 26.84M |
| Plus Therapeutics | 25.74M |
| Skye Bioscience | 25.08M |
| Barinthus Biotherapeutics | 25.00M |